Consolidated Statements of Loss and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
EXPENSES
Research and development	$ 15,814	$ 30,078	$ 23,966
General and administrative	11,436	10,722	9,128
Total operating expenses	27,250	40,800	33,094
OTHER INCOME (EXPENSE)
Interest income	825	199	17
Interest expense [note 9]	(2,853)	(1,789)
Change in fair value of contingent consideration [note 6 and note 7]	(528)
Other income/(expense)	(9)	40	(75)
Total other income (expense)	(2,565)	(1,550)	(58)
Net loss and comprehensive loss	$ (29,815)	$ (42,350)	$ (33,152)
Basic net loss per common share [note 11 [i]]	$ (1.5)	$ (4)	$ (4.08)
Diluted net loss per common share [note 11 [i]]	$ (1.5)	$ (4)	$ (4.08)
Shares used in computation of basic net loss per common share [note 11 [i]]	19,827,354	10,593,034	8,119,836
Shares used in computation of Diluted net loss per common share [note 11 [i]]	19,827,354	10,593,034	8,119,836